{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:45:42Z","timestamp":1789069542593,"version":"build-2803163510"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Pediatric heart failure (HF) is a complex syndrome with high morbidity, characterized by distinct epidemiological profiles globally. While congenital heart disease and cardiomyopathies predominate in developed regions, rheumatic heart disease and delayed surgical interventions drive the burden in low- and middle-income countries. This review elucidates the unique pathophysiology of pediatric HF, which differs significantly from that of adult HF in terms of developmental cardiac physiology, molecular signaling, and maladaptive ventricular remodeling. Diagnosis remains challenging due to nonspecific symptoms and the limitations of adult-derived classification systems and biomarkers. Management strategies are evolving beyond traditional regimens, and clinicians are increasingly adopting the \u201cfour-pillar\u201d therapies, including Angiotensin Receptor\u2013Neprilysin Inhibitors and sodium\u2013glucose cotransporter-2 inhibitors. However, pediatric-specific evidence remains limited compared to adult data. Notably, the recent PANORAMA-HF trial showed that sacubitril\/valsartan was similarly effective to enalapril but did not achieve statistically superior outcomes in children. For end-stage HF, ventricular assist devices and heart transplantation are critical, though donor shortages persist. Furthermore, pulmonary artery banding has re-emerged as a surgical strategy to induce left ventricular recovery in young children with dilated cardiomyopathy. Given the disparity in outcomes and the reliance on extrapolated adult data, there is an urgent need for large-scale, pediatric-specific clinical trials to optimize global management strategies.<\/jats:p>","DOI":"10.4103\/apc.apc_371_25","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T13:00:15Z","timestamp":1767272415000},"page":"313-322","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Challenges in managing pediatric heart failure, especially in resource-limited settings"],"prefix":"10.4103","volume":"18","author":[{"given":"Lamk","family":"Kadiyani","sequence":"first","affiliation":[{"name":"Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivasubramanian","family":"Ramakrishnan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,1]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: Executive summary","volume":"33","author":"Kirk","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13643-018-0717-6","article-title":"Epidemiology of heart failure in pediatric populations in low- and middle-income countries: A protocol for a systematic review","volume":"7","author":"Sibetcheu","year":"2018","journal-title":"Syst Rev"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/1995-705X.192556","article-title":"Heart failure in children","volume":"17","author":"Jayaprasad","year":"2016","journal-title":"Heart Views"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/apc.apc_71_24","article-title":"The outcome of surgery for congenital heart disease in India: A systematic review and metanalysis","volume":"17","author":"Kadiyani","year":"2024","journal-title":"Ann Pediatr Cardiol"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/apc.apc_153_21","article-title":"Pediatric cardiology: Is India self-reliant?","volume":"14","author":"Ramakrishnan","year":"2021","journal-title":"Ann Pediatr Cardiol"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1574887109666140908125841","article-title":"Pediatric heart failure in the developing world","volume":"9","author":"Ramakrishnan","year":"2014","journal-title":"Rev Recent Clin Trials"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"244","DOI":"10.21037\/cdt.2019.08.03","article-title":"An overview of heart failure in low- and middle-income countries","volume":"10","author":"Agbor","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"e220779","DOI":"10.1001\/jamacardio.2022.0779","article-title":"A child with heart failure and bumpy lesions on the back","volume":"7","author":"Arvind","year":"2022","journal-title":"JAMA Cardiol"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1136\/heartjnl-2011-300792","article-title":"Prevalence and outcome of subclinical rheumatic heart disease in India: The RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study","volume":"97","author":"Saxena","year":"2011","journal-title":"Heart"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ijcard.2017.09.184","article-title":"Echocardiographic prevalence of rheumatic heart disease in Indian school children using World Heart Federation criteria \u2013 A multi site extension of RHEUMATIC study (the e-RHEUMATIC study)","volume":"249","author":"Saxena","year":"2017","journal-title":"Int J Cardiol"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12098-019-03128-7","article-title":"Rheumatic fever and rheumatic heart disease in children","volume":"87","author":"Arvind","year":"2020","journal-title":"Indian J Pediatr"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"e001106","DOI":"10.1136\/bmjpo-2021-001106","article-title":"Non-specific aortoarteritis (NSAA) in children: A prospective observational study","volume":"5","author":"Gupta","year":"2021","journal-title":"BMJ Paediatr Open"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jaccas.2021.10.007","article-title":"Heart failure in a child: Multimodality approach leading to an unusual cause","volume":"3","author":"Karuru","year":"2021","journal-title":"JACC Case Rep"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0974-2069.84655","article-title":"Hypocalcemic cardiomyopathy presenting as cardiogenic shock","volume":"4","author":"Gupta","year":"2011","journal-title":"Ann Pediatr Cardiol"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/apc.apc_188_25","article-title":"Dapagliflozin in pediatric heart failure with reduced ejection fraction \u2013 A randomized pilot study","volume":"18","author":"Faisal","year":"2025","journal-title":"Ann Pediatr Card"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/apc.apc_249_25","article-title":"Randomized comparison of continuous versus intermittent bolus furosemide in neonatal heart failure","volume":"18","author":"Ahmadipour","year":"2025","journal-title":"Ann Pediatr Card"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4103\/apc.apc_100_25","article-title":"Clinical and echocardiographic features of right ventricular dysfunction and biventricular dysfunction in children","volume":"18","author":"Loss","year":"2025","journal-title":"Ann Pediatr Card"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4103\/apc.apc_158_25","article-title":"New hope for young hearts: A systematic review of sodium glucose cotransporter 2 inhibitors in pediatric heart failure","volume":"18","author":"Mangkuliguna","year":"2025","journal-title":"Ann Pediatr Card"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4103\/apc.apc_252_25","article-title":"Effects of sacubitril\/Valsartan, an angiotensin receptor-neprilysin inhibitor, on renal impairment in patients with cyanotic congenital heart disease","volume":"18","author":"Kandukuri","year":"2025","journal-title":"Ann Pediatr Card"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cca.2020.09.010","article-title":"Pathophysiology and molecular signalling in pediatric heart failure and VAD therapy","volume":"510","author":"Ragusa","year":"2020","journal-title":"Clin Chim Acta"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1573403X12666151119164525","article-title":"The pathophysiology of heart failure in children: The basics","volume":"12","author":"Knudson","year":"2016","journal-title":"Curr Cardiol Rev"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1058-9813(00)00048-5","article-title":"Pathophysiology of pediatric heart failure","volume":"11","author":"Auslender","year":"2000","journal-title":"Prog Pediatr Cardiol"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/S1047951123000331","article-title":"Paediatric heart failure \u2013 Understanding the pathophysiology and the current role of cardiac biomarkers in clinical practice","volume":"33","author":"McGinn","year":"2023","journal-title":"Cardiol Young"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pedneo.2017.01.001","article-title":"Pediatric heart failure: A practical guide to diagnosis and management","volume":"58","author":"Masarone","year":"2017","journal-title":"Pediatr Neonatol"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1161\/CIR.0000000000001245","article-title":"Evaluation and management of chronic heart failure in children and adolescents with congenital heart disease: A scientific statement from the American Heart Association","volume":"150","author":"Amdani","year":"2024","journal-title":"Circulation"},{"key":"R26-20260420","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/apc.apc_223_25","article-title":"The grown-up congenital heart disease dilemma in India: A call for urgent reform in adult congenital cardiac care","volume":"18","author":"Mantoo","year":"2025","journal-title":"Ann Pediatr Cardiol"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.123.066605","article-title":"Sacubitril\/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A randomized, multicenter, double-blind trial","volume":"150","author":"Shaddy","year":"2024","journal-title":"Circulation"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.healun.2024.01.012","article-title":"Sacubitril-valsartan versus ACE\/ARB in pediatric heart failure: A retrospective cohort study","volume":"43","author":"Hale","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.109.927988","article-title":"Enalapril in infants with single ventricle: Results of a multicenter randomized trial","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1651-2227.1991.tb11905.x","article-title":"Enalapril in children with congestive heart failure","volume":"80","author":"Eronen","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"209","DOI":"10.14238\/pi29.9-10.1989.209-14","article-title":"Captopril treatment in rheumatic heart disease with congestive heart failure. A preliminary report","volume":"29","author":"Sastrosubroto","year":"1989","journal-title":"Paediatr Indones"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/01.CIR.96.5.1507","article-title":"Enalapril does not enhance exercise capacity in patients after Fontan procedure","volume":"96","author":"Kouatli","year":"1997","journal-title":"Circulation"},{"key":"R34-20260420","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0002-9149(01)01858-6","article-title":"Effective dose and cardiovascular effects of cilazapril in children with heart failure","volume":"88","author":"Hazama","year":"2001","journal-title":"Am J Cardiol"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jchf.2022.10.005","article-title":"How to initiate and uptitrate GDMT in heart failure: Practical stepwise approach to optimization of GDMT","volume":"10","author":"Bozkurt","year":"2022","journal-title":"JACC Heart Fail"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00246-022-02983-0","article-title":"Early clinical experience with dapagliflozin in children with heart failure","volume":"44","author":"Newland","year":"2023","journal-title":"Pediatr Cardiol"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00246-024-03604-8","article-title":"Dapagliflozin use in children with advanced heart failure undergoing heart transplantation: A Matched Case-Control Study","volume":"46","author":"Newland","year":"2025","journal-title":"Pediatr Cardiol"},{"key":"R38-20260420","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00246-023-03332-5","article-title":"Experience with SGLT2 inhibitors in patients with single ventricle congenital heart disease and fontan circulatory failure","volume":"46","author":"Konduri","year":"2025","journal-title":"Pediatr Cardiol"},{"key":"R39-20260420","doi-asserted-by":"crossref","DOI":"10.1007\/s00246-025-04025-x","article-title":"Use of SGLT2 inhibitors in pediatric heart failure: A multi-center study","author":"Butts","year":"2025","journal-title":"Pediatr Cardiol"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.33963\/v.phj.102194","article-title":"Treatment with dapagliflozin in pediatric patients with heart failure in four different etiologies: A case series","volume":"82","author":"Kurkiewicz-Sawczak","year":"2024","journal-title":"Kardiol Pol"},{"key":"R41-20260420","doi-asserted-by":"crossref","first-page":"133384","DOI":"10.1016\/j.ijcard.2025.133384","article-title":"The efficacy and safety of dapagliflozin in pediatric heart failure","volume":"435","author":"Kumar","year":"2025","journal-title":"Int J Cardiol"},{"key":"R42-20260420","first-page":"5243594","article-title":"Feasibility and safety of sodium glucose cotransporter-2 inhibitors in adults with heart failure after the fontan procedure","volume":"2022","author":"Muneuchi","year":"2022","journal-title":"Case Rep Cardiol"},{"key":"R43-20260420","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00259-003-1306-y","article-title":"Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy","volume":"30","author":"Maunoury","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R44-20260420","first-page":"52","volume":"78","author":"Saucedo","year":"2008","journal-title":"Evaluation of the effect of carvedilol in children with dilated cardiomyopathy Arch Cardiol Me\u00d7"},{"key":"R45-20260420","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.clinthera.2008.04.007","article-title":"Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: A 12-month, two-center, open-label study","volume":"30","author":"Bajcetic","year":"2008","journal-title":"Clin Ther"},{"key":"R46-20260420","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00246-012-0527-x","article-title":"The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: A prospective, randomized-controlled study","volume":"34","author":"Huang","year":"2013","journal-title":"Pediatr Cardiol"},{"key":"R47-20260420","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/S0735-1097(99)00421-0","article-title":"A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta-adrenoceptor antagonist treatment","volume":"34","author":"Ostman-Smith","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R48-20260420","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3923\/pjbs.2009.451.454","article-title":"Influence of metoprolol on systolic and diastolic function in children with heart failure","volume":"12","author":"Ghader","year":"2009","journal-title":"Pak J Biol Sci"},{"key":"R49-20260420","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure: A randomized controlled trial","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"key":"R50-20260420","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0735-1097(02)02570-6","article-title":"Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment","volume":"40","author":"Azeka","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R51-20260420","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00380-008-1102-5","article-title":"Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease","volume":"24","author":"Nishiyama","year":"2009","journal-title":"Heart Vessels"},{"key":"R52-20260420","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1017\/S1047951107000844","article-title":"A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of fallot","volume":"17","author":"Norozi","year":"2007","journal-title":"Cardiol Young"},{"key":"R53-20260420","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s00246-021-02565-6","article-title":"Carvedilol does not improve exercise performance in fontan patients: Results of a crossover trial","volume":"42","author":"Butts","year":"2021","journal-title":"Pediatr Cardiol"},{"key":"R54-20260420","first-page":"684","article-title":"Preliminary study on the effect of carvedilol on children with primary endocardial fibroelastosis","volume":"46","author":"Li","year":"2008","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"R55-20260420","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-5273(01)00413-2","article-title":"Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol","volume":"79","author":"Buchhorn","year":"2001","journal-title":"Int J Cardiol"},{"key":"R56-20260420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/apc.APC_94_21","article-title":"Efficacy and safety of propranolol in infants with heart failure due to moderate-to-large ventricular septal defect (VSD-PHF study) \u2013 A prospective randomized trial","volume":"14","author":"Ramakrishnan","year":"2021","journal-title":"Ann Pediatr Cardiol"},{"key":"R57-20260420","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2012.01.020","article-title":"Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: Is there an influence of beta-blocker dose? Findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R58-20260420","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/adc.56.12.934","article-title":"Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease","volume":"56","author":"Hobbins","year":"1981","journal-title":"Arch Dis Child"},{"key":"R59-20260420","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0002-9149(91)90249-K","article-title":"Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect","volume":"68","author":"Kimball","year":"1991","journal-title":"Am J Cardiol"},{"key":"R60-20260420","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","article-title":"Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure","volume":"70","author":"Bonnet","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R61-20260420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s002460010144","article-title":"Effects of transdermal nitroglycerin in children with congestive heart failure: A Doppler echocardiographic study","volume":"22","author":"Vaksmann","year":"2001","journal-title":"Pediatr Cardiol"},{"key":"R62-20260420","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.semtcvs.2018.03.003","article-title":"Worldwide experience of a durable centrifugal flow pump in pediatric patients","volume":"30","author":"Conway","year":"2018","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R63-20260420","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MAT.0000000000000983","article-title":"Bridge to transplant with ventricular assist device support in pediatric patients with single ventricle heart disease","volume":"66","author":"Chen","year":"2020","journal-title":"ASAIO J"},{"key":"R64-20260420","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.healun.2020.02.007","article-title":"Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis","volume":"39","author":"O\u2019Connor","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R65-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/apc.apc_67_24","article-title":"Pediatric cardiac procedures in India: Who bears the cost?","volume":"17","author":"Faisal","year":"2024","journal-title":"Ann Pediatr Cardiol"},{"key":"R66-20260420","doi-asserted-by":"crossref","first-page":"e14615","DOI":"10.1111\/petr.14615","article-title":"Three decades of collaboration through the pediatric heart transplant society registry: A journey through registry data with a highlight on children with single ventricle anatomy","volume":"28","author":"Richmond","year":"2024","journal-title":"Pediatr Transplant"},{"key":"R67-20260420","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The international thoracic organ transplant registry of the International Society for heart and lung transplantation: Thirty-sixth adult heart transplantation report \u2013 2019; focus theme: Donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R68-20260420","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.healun.2017.10.021","article-title":"Outcome after heart transplantation from donation after circulatory-determined death donors","volume":"36","author":"Messer","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R69-20260420","doi-asserted-by":"crossref","first-page":"e13244","DOI":"10.1111\/petr.13244","article-title":"Waste not, want not: Maximizing use of pediatric marginal donor hearts","volume":"22","author":"Kirk","year":"2018","journal-title":"Pediatr Transplant"},{"key":"R70-20260420","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/heartjnl-2015-309110","article-title":"\u2018End-stage\u2019 heart failure therapy: Potential lessons from congenital heart disease: From pulmonary artery banding and interatrial communication to parallel circulation","volume":"103","author":"Schranz","year":"2017","journal-title":"Heart"},{"key":"R71-20260420","doi-asserted-by":"crossref","first-page":"151","DOI":"10.21037\/tp.2019.04.09","article-title":"Pulmonary artery banding in dilative cardiomyopathy of young children: Review and protocol based on the current knowledge","volume":"8","author":"Schranz","year":"2019","journal-title":"Transl Pediatr"},{"key":"R72-20260420","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1017\/S1047951114002406","article-title":"Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers","volume":"25","author":"Rupp","year":"2015","journal-title":"Cardiol Young"},{"key":"R73-20260420","first-page":"248","article-title":"Advances in the treatment of pulmonary artery banding in children with dilated cardiomyopathy","volume":"40","author":"Wei","year":"2024","journal-title":"Chin J Thorac Cardiovasc Surg"},{"key":"R74-20260420","article-title":"Single-center experience with sacubitril\/valsartan in patients with congenital heart disease","author":"Konduri","year":"2025","journal-title":"Pediatr Cardiol"},{"key":"R75-20260420","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/2150135119825599","article-title":"Early experience with sacubitril\/valsartan in adult patients with congenital heart disease","volume":"10","author":"Lluri","year":"2019","journal-title":"World J Pediatr Congenit Heart Surg"}],"container-title":["Annals of Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_371_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:25Z","timestamp":1786647505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_371_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/apc.apc_371_25","relation":{},"ISSN":["0974-2069","0974-5149"],"issn-type":[{"value":"0974-2069","type":"print"},{"value":"0974-5149","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}